US moves to restrict Chinese genomics firms over Xinjiang concerns

· Health · United States · China

Washington banned imports from three Chinese genomics companies after concluding they have ties to forced labour in Xinjiang, with the government saying it believes BGI Group tests genetic material of people from the region. The action widens US restrictions on Chinese biotechnology beyond trade and security into human-rights concerns over data and genetic testing.

Why it matters：Genomic data is becoming a national-security asset, and restrictions on testing could reshape global biomedical collaboration.

Key points

  • Three Chinese genomics companies face US import bans.
  • The US cited forced labour in Xinjiang.
  • BGI Group was named in the action.

Sources (original reporting)

More stories from this day